MariMed Inc.
MRMD
$0.11
-$0.02-15.39%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 157.16M | 157.99M | 157.96M | 157.86M | 156.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 157.16M | 157.99M | 157.96M | 157.86M | 156.07M |
| Cost of Revenue | 96.50M | 96.45M | 95.10M | 90.39M | 88.53M |
| Gross Profit | 60.66M | 61.53M | 62.87M | 67.48M | 67.54M |
| SG&A Expenses | 59.66M | 60.52M | 59.01M | 59.90M | 58.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 156.17M | 156.97M | 154.10M | 150.28M | 146.88M |
| Operating Income | 993.00K | 1.02M | 3.86M | 7.58M | 9.19M |
| Income Before Tax | -6.76M | -6.96M | -3.97M | -10.35M | -9.81M |
| Income Tax Expenses | 9.13M | 9.30M | 8.16M | 3.72M | 7.53M |
| Earnings from Continuing Operations | -15.89 | -16.26 | -12.13 | -14.07 | -17.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -50.00K | -63.00K | -37.00K | -64.00K | -38.00K |
| Net Income | -15.94M | -16.32M | -12.16M | -14.13M | -17.38M |
| EBIT | 993.00K | 1.02M | 3.86M | 7.58M | 9.19M |
| EBITDA | 12.56M | 12.32M | 14.72M | 17.95M | 19.31M |
| EPS Basic | -0.04 | -0.04 | -0.03 | -0.04 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.04 | -0.04 | -0.03 | -0.04 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.53B | 1.52B | 1.52B | 1.51B | 1.50B |
| Average Diluted Shares Outstanding | 1.53B | 1.52B | 1.52B | 1.51B | 1.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.75% | -0.74% | -1.36% | -1.17% | -1.00% |